AVROBIO
BioTech/Drugs - Cambridge, Massachusetts, US
AVROBIO Details
Our vision is to bring personalized gene therapy to the world. We target the root cause of genetic disease by introducing a functional copy of the affected gene into patients’ own hematopoietic stem cells (HSCs), with the goal of durably expressing the therapeutic protein throughout the body, including the central nervous system. Our first-in-class pipeline includes clinical programs for Gaucher disease and Hunter syndrome, as well as a preclinical program for Pompe disease. Our proprietary plato® gene therapy platform is scalable for planned global commercialization. We are headquartered in Cambridge, Mass. For additional information, visit avrobio.com, and follow us on Twitter and LinkedIn.
AVROBIO Technologies
Email Providers
Outlook
Load Balancers
Ubuntu
Web Performance Monitoring
New Relic
Hosting
Google Cloud Hosting
Other
Mobile Friendly